From: Circular RNA: metabolism, functions and interactions with proteins
Manner | CircRNA | Protein | Direct Effect | Biological Function | Correlationa | Refs |
---|---|---|---|---|---|---|
Altering interactionsbetween proteins | circFoxo3 | p53, MDM2 | induce mutant p53 ubiquitination | pro-apoptosis | P | [92] |
circFoxo3 | p21, CDK2 | dampen the activity and accessibility of CDK2 | cell cycle arrest in G1 phase | P | [93] | |
circNfix | YBX1, Nedd4l | induce YBX1 ubiquitination and inhibit its nucleartranslocation | cell cycle arrest, anti-angiogenesis,anti-regeneration | U | [25] | |
circADD3 | CDK1, EZH2 | phosphorylate EZH2 and induce its ubiquitination | anti-metastasis | P | [94] | |
circAmotl1 | PDK1, AKT | phosphorylate AKT and promote pAKT nucleartranslocation | anti-apoptosis, cardio-protection | P | [95] | |
circGLI1 | p70S6K2, GSK3β | phosphorylate GSK3β | pro-metastasis | P | [96] | |
circCTNNB1 | DDX3, YY1 | transactivate YY1 | tumor progression | P | [97] | |
circCUX1 | EWSR1, MAZ | transactivate MAZ | pro-Warburg effect, tumor progression | P | [98] | |
circACC1 | β and γ subunits of AMPK | stabilize and activate AMPK | metabolic reprogramming | N | [99] | |
circCcnb1 | H2AX, (wild-type p53) | free Bclaf1 from p53 | cell survival | P | [100] | |
circCcnb1 | H2AX, (Bclaf1) | wrap Bclaf1 by H2AX | cell death | N | [100] | |
circCcnb1 | Ccnb1, CDK1 | deactivate Ccnb1 and retain it in the cytoplasm | cell cycle arrest in G2 phase | N | [101] | |
Blocking proteinsfrom DNA | circHuR | CNBP | sequester CNBP from the HuR promoter | tumor suppression | N | [102] |
circSCMH1 | MeCP2 | tether MeCP2 and relieve its repression upon thetarget gene transcription | neuroprotection post stroke | P | [103] | |
circSamd4 | PURA, PURB | tether PURA/B and relieve their repression uponMHC transcription | pro-myogenesis | U | [104] | |
ACR | DNMT3B | tether DNMT3B and decrease the methylation of thePink1 promoter | anti-autophagy | U | [105] | |
cia-cGAS | cGAS | block cGAS from self-DNA and inhibit its enzymatic activity | maintaining HSCs quiescent | U | [106] | |
Blocking proteinsfrom RNA | circSMARCA5 | SRSF1 | tether SRSF1 and suppress its splicing activity (SRSF3, PTBP1) | anti-migration | N | [107] |
circSMARCA5 | SRSF1 | tether SRSF1 and suppress its splicing activity (VEGFA) | anti-angiogenesis | N | [108] | |
circPABPN1 | HuR | sequester HuR and destabilize PABPN1 mRNA | anti-proliferation | N | [109] | |
circPABPN1 | HuR | sequester HuR and destabilize Atg16L1 mRNA | anti-autophagy | U | [110] | |
circZKSCAN1 | FMRP | sequester FMRP from combing with CCAR1 mRNA | anti-stemness, tumor quiescence | U | [111] | |
circMTO1 | TRAF4 | deactivate Eg5 translation | chemosensitization | U | [112] | |
circMMP9 | AUF1 | relieve the inhibition of MMP9 mRNA | pro-metastasis | P | [113] | |
circANRIL | PES1 | prevent pre-rRNA maturation and impair ribosome biogenesis | anti-atherosclerosis | N | [114] | |
circPPM1F | HuR | sequester HuR and destabilize PPM1F mRNA | M1 macrophage activation | N | [115] | |
Blocking proteinsfrom proteins | circGSK3β | GSK3β | block GSK3β from β-catenin | pro-metastasis | N | [116] |
CDR1as | p53 | block p53 from MDM2 | tumor suppression | U | [22] | |
circ102171 | CTNNBIP1 | block CTNNBIP1 from β-catenin | tumor progression | U | [117] | |
circH19 | PTBP1 | tether PTBP1 and inhibit its ability to cleave and activate SREBP1 | adipogenesis | U | [118] | |
circECE1 | c-myc | block c-myc from SPOP | pro-Warburg effect | P | [119] | |
SCAR | ATP5B | block mPTP from CypD | anti-metaflammation | U | [50] | |
Recruiting transcriptionfactors to chromatin | circRHOT1 | TIP60 | recruit TIP60 to the NR2F6 promoter and initiate transcription | tumor progression | P | [47] |
circAnks1a | YBX1 | recruit YBX1 to the VEGFB promoter and activate transcription | central sensitization, painbehavioral hypersensitivity | U | [120] | |
circ0005276 | FUS | recruit FUS to the XIAP promoter | tumor progression | P | [121] | |
circPOK | ILF2/3 complex | potentiate the affinity of ILF2/3 to the IL-6 promoter | pro-angiogenesis | N | [122] | |
Recruiting modifyingenzymes to chromatin | circFECR1 | TET1 | induce demethylation and activate FLI1 transcription | pro-tumorigenesis | P | [123] |
circMRPS35 | KAT7 | induce the acetylation of H4K5 and activate FOXO1/3a transcription | tumor suppression | U | [124] | |
circAGFG1 | EZH2 | induce H3K27me3 of the p53 promoter | tumor progression | U | [125] | |
circLRP6 | LSD1, EZH2 | induce H3K27me3 and H3K4me2 of the KLF2 and APC promoter | tumor progression | P | [126] | |
Recruiting chromatinremodelers | circDONSON | NURF complex | recruit the NURF complex to the SOX4 promoter and activate itstranscription | tumor progression | U | [127] |
circKcnt2 | NuRD complex | recruit the NuRD complex to the Batf promoter and inhibit itstranscription | anti-inflammation | U | [128] | |
Ternary complexesregulating RNA stability | circNSUN2 | IGF2BP2, (HMGA2 mRNA) | stabilize HMGA2 mRNA | pro-metastasis | P | [43] |
circPOK | ILF2/3, (mRNA of IL-6 andVEGF) | stabilize the mRNA of IL-6 and VEGF | tumor progression, pro-angiogenesis | N | [122] | |
circFNDC3B | IGF2BP3, (CD44 mRNA) | stabilize CD44 mRNA | tumor progression | P | [129] | |
Ternary complexesregulating translation | circMALAT1 | Ribosome, (PAX5 mRNA) | retard PAX5 translation | self-renewal of HCC stem cells | U | [130] |
circYap | eIF4G, PABP, (Yap mRNA) | interrupt the assembly of Yap translation initiation machinery | tumor suppression | N | [131] | |
circMYBL2 | PTBP1, (FLT3 mRNA) | promote FLT3 translation | AML progression | P | [132] | |
Translocating proteinsto the nucleus | circAmotl1 | c-myc | retain c-myc in the nucleus and increase its affinity to targets | pro-tumorigenesis | P | [46] |
circAmotl1 | STAT3 | facilitate the nuclear translocation of STAT3 | pro-wound repair | P | [133] | |
circDNMT1 | p53, AUF1 | facilitate the nuclear translocation of p53 and AUF1, elevatingLC3B level and stabilizing DNMT1 mRNA, respectively | pro-autophagy, anti-senescence,tumor progression | P | [134] | |
circABCC1 | β-catenin | redistribute β-catenin | tumor progression | U | [135] | |
circSOX4 | β-catenin | translocate β-catenin to the nucleus | tumor progression | P | [136] | |
Translocating proteinsto the cytoplasm | circFoxo3 | ID-1, E2F1, FAK, HIF1α | retain these proteins in the cytoplasm and arrest their functions | pro-senescence | P | [137] |
circFOXP1 | PTBP1 | translocate PTBP1 to the cytoplasm and stabilize PKLR mRNA | pro-Warburg effect, tumor progression | N | [138] | |
circSTAG1 | ALKBH5 | retain ALKBH5 in the cytoplasm | anti-depression | U | [139] | |
circBACH1 | HuR | translocate HuR to the cytoplasm | cell cycle progression | P | [140] | |
circZFP609 | HIF1α | retain HIF1α in the cytoplasm | anti-angiogenesis | U | [141] | |
circCCAC1 | EZH2 | retain EZH2 in the cytoplasm | pro-metastasis | P | [24] | |
Other regions | circERBB2 | PA2G4 | translocate PA2G4 to the nucleolus and promote rDNA transcription | tumor progression | P | [142] |
circSKA3 | Tks5, Integrin β1 | recruit Tks5 to the membrane and co-localize with integrin β1;induce the formation of invadopodia | pro-invasion, pro-metastasis | P | [143] | |
mecciND1, mecciND5 | RPA32, hnRNPA1, TOM40 | interact with TOM40 and facilitate the mitochondrial importationof RPA32 and hnRNPA1, respectively | metabolism of mtDNA and mtRNA;not clear | U | [143] | |
mecciRNAs | PNPASE | control the mitochondrial importation of mecciRNAs | not clear | U | [52] | |
Unknown orunconfirmedmanners | circ0011460 | PGT | just verify the interaction by RIP; increase PGT level | positive correlation with pre-eclampsia | P | [144] |
circ0075932 | PUM2 | just verify the interaction by RNA pull-down; increase PUM2 level | pro-inflammation, pro-apoptosis | U | [145] | |
circFndc3b | FUS | just verify the interaction by RIP; decrease FUS level | pro-angiogenesis, anti-apoptosis | P | [146] | |
circZNF292 | LDHA | just verify the interaction by RIP; increase LDHA level | pro-glycolysis | N | [147] | |
circAmotl1 | pAKT | just verify the interaction by RIP; activate AKT pathway | chemoresistance | P | [148] | |
circ0075804 (circE2F3) | HNRNPK | stabilize E2F3 mRNA; the formation of ternary complex is notconfirmed | pro-proliferation, anti-apoptosis | P | [149] | |
circPTK2 | vimentin | just verify the interaction by RNA pull-down | tumor progression | U | [150] | |
circ406961 | ILF2 | just verify the interaction by RNA pull-down; decrease ILF2 leveland suppress the STAT3/JNK pathway | anti-inflammation (induced by PM2.5) | U | [151] | |
circBbs9 | Ccnd2 | just verify the interaction by RIP; increase Ccnd2 level | pro-proliferation | U | [152] | |
circHECTD1 | ZC3H12A | reduce ZC3H12A ubiquitination by attenuatinginteraction between ZC3H12A and HECTD1; this study only showscircHECTD1 negatively correlates with HECTD1 | deactivation and pro-apoptosis ofalveolar macrophage activated bysilica | N | [153] | |
circFOXK2 | YBX1, hnRNPK | enhance the interaction of YBX1 and hnRNPK with NUF2 andPDXK; lack a detailed mechanism | tumor progression | N | [154] | |
circMUC16 | ATG13 | just verify the interaction by RNA pull-down; increase ATG13 level | pro-autophagy | P | [155] | |
circUBR5 | QKI, NOVA1 (U1 snRNA) | probably participate in RNA splicing; lack a detailed mechanism | non-functional phenotype | U | [156] | |
circNF1–419 | Dynamin-1, Adaptor protein2 B1 (AP2B1) | just verify the interaction by RNA pull-down and RIP; lack a detailed mechanism | pro-autophagy, senile dementiadelay | U | [157] | |
circNOL10 | SCML1 | just verify the interaction by RNA pull-down; increase SCML1 level | tumor suppression | U | [158] | |
circHipk3 | Notch1 intracellular domain(N1ICD) | verify the interaction by RNA pull-down and RIP; increase N1ICDexpression, stability, acetylation; lack a detailed mechanism | cardiac regeneration | U | [159] | |
 | cIARS | ALKBH5 | inhibit the ALKBH5-mediated interaction between Beclin1 andBcl-2; lack a detailed mechanism | pro-autophagy, pro-ferroptosis | U | [160] |